Login to Your Account



Other News To Note


Friday, April 13, 2012

• Cardio3 Biosciences SA, of Mont-Saint-Guibert, Belgium, received good manufacturing practice certification for its production facilities in Mont-Saint-Guibert from the Federal Agency for Medicines and Health Products of Belgium. The facilities are used to manufacture the company's lead product, C3BS-CQR-1, which is in development for heart failure.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription